Even correctly spelled words can create significant regulatory risk when used in the wrong clinical context.
Examples include:
• Patients vs Patents
• Fetal vs Maternal references
• Inconsistent terminology between sections
• Context-sensitive wording errors
These issues often require time-consuming manual review and can lead to costly delays if missed.
ContextRx is designed specifically for pharmaceutical content review.
Unlike general-purpose grammar tools, ContextRx analyses content using pharmaceutical-specific language models trained on FDA-approved drug labelling data.
The platform helps teams:
✓ Identify context-sensitive language issues
✓ Improve document consistency
✓ Reduce manual review effort
✓ Support regulatory submission quality
Improve quality before submission and reduce review cycles
Identify context-sensitive errors earlier in the authoring process
Deliver greater consistency and quality across client projects
Reduce review time and improve document quality
Review content before formal regulatory assessment.
Identify terminology and context issues before client delivery.
Support consistency across pharmaceutical documentation.
Work directly with a local partner who understands your business and can provide responsive support throughout the evaluation process.
See ContextRx in action with tailored demonstrations focused on your specific regulatory, medical writing or quality review challenges.
Receive practical support when assessing ContextRx within your organisation, helping you validate potential benefits before wider adoption.
Thirstland has extensive experience supporting quality-critical industries with specialist technical solutions, helping organisations improve accuracy, compliance and operational efficiency.
Complete the contact form below and we’ll arrange a brief introductory discussion and demonstration.
+44 7810 344 302
michael@thirstland.co.uk
Monday to Friday – 9am to 5pm
Saturday & Sunday – Closed
25 Pool Street, Bodmin, Cornwall, PL31 2HB